TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Sleep apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Knowledge and perception of adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with positive FAI by diagnostic gold standard
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with negative response of FAI by dosing markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the proportion of patients being neutralizing antibody positive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Length of Subject Survival
Endpoint domain: Mortality/survival
Primary endpoint: all cause mortality at day 200
Endpoint domain: Mortality/survival
Primary endpoint: Changes in oxygen desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in non-invasive blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average Number of Coughs Per Hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Usability of the Auto-injector (AI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Measurement of Uterine Artery Pulsatility Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Measurement of Uterine Artery Resistance Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Appearance of Sub Endometrial Blood Flow in All Patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: rate of device related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Intra-arterial mean BP below 65 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in box trainer scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recurrence of Cervical Intraepithelial Neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: time for completion of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Local Skin Reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction of Visceral Adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pharmacokinetic properties of lorcaserin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Relative bioavailability of acetaminophen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of Donors Whose Cells Were Successfully Mobilized and Collected With a Sufficient CD34+ Cell Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and grade of adverse events related to vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Stool weight output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cleansing success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: locomotor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fecal incontinence episode per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in rehospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Assessment of loneliness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of EEG biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol Use Disorders Identification Test (AUDIT) Total
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to inadequate asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alanine aminotransferase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Aspartate aminotransferase (AST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Alkaline phosphatase (ALP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Rate of Alzheimer's Disease conversion
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants Alive and Free of Progression
Endpoint domain: Mortality/survival
Primary endpoint: Primary VAS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Need for postnatal ECMO therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in physical functioning scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Murmur intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Treatment-emergent Adverse Event(s) (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of the influenza vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Vascular calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change from baseline in Agility fatigue index
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Comfort in wearing contact lenses
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Investigators Global Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global Base Changes of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Health Related Quality of Life Using a Survey With 49 Questions
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of identifying patients with coronary artery stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reorientation onset of body segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall Efficacy Score (FES-I)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Association of single nucleotide polymorphisms with contralateral breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants with comparable FFR ratio recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of DFU recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tremor scale measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assessment of functional activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical and Neurological Examination Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ophthalmological Examination Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oxygen consumption in mL per kilogram per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Children Fully Vaccinated at Hospital Discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of the radial artery as a conduit for CABG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Clinical Response at Week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of genes, proteins, and neurotoxicants associated with ALS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Nasal Potential Difference (NPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spasticity measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of hormones and neuropeptides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: muscle protein synthesis (MPS) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of single pool Kt/V
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC scale)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reversal of cardiometabolic abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Number of Post-operative Doses of Analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lipids (LDLc, HDLc, cholesterol, and triglyceride)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscle Sympathetic Nerve Activity - Microneurography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in The Diabetes Empowerment Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of medication doses directly observed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clearance rate of BCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Re-myocardial infarct
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Re-hospitalization for heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anteroposterior displacement of center of pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apixaban plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening severity of hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of ACOS patients among COPD-diagnosed patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Fear of Pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Predictive biomarker for response to aflibercept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subject reported perspectives on WAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of caregiver reported perspectives on WAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Analysis of tolerability of treatment by subjects
Endpoint domain: Adverse events/effects
Primary endpoint: Reductions in Arizona Sexual Experience Scale (ASEX) Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reductions in Massachusetts General Hospital Sexual Dysfunction (MGH-SD) Inventory Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Patients Scored as Having the Surgical Technique Performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Faecal microbiota changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory/thrombotic biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: New bone formation in the sinus cavity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in intra-operative anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Invasive mechanical ventilation or death
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients win from oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance covered during a 6-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triceps surae maximal isometric force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endurance time at 75 % of peak workload on cycle ergometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step Cadence Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stride Length Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in repeated finger-tapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with physiological signal abnormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose levels percent time in target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adolescent quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: device related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Reduction in BPI-SF Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Reduction in BPI-SF Interference Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Short Term Blood Perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Long Term Blood Perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Index of Microcirculatory Resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Mean Residual Expression (MRE%) of NFAT-related Cytokine Expression and Acute Cellular Rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Mean Residual Expression (MRE%) of NFAT-related Cytokine Expression and Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Health access for cervical cancer screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hours of continuous comfortable contact lens wear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact Lens Questionnaire-8 (CLDEQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Managing Symptoms Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serious Adverse Device Effects (SADE)
Endpoint domain: Adverse events/effects
Primary endpoint: StO2 measurement from intestines, liver and flank
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral StO2 measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse and Tissue oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drinking Quantity Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of bone formation volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular hypertrophy regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tinnitus Reaction Questionnaire (TRQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tinnitus Handicap Questionnaire (THQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to First Co-primary Outcome
Endpoint domain: Mortality/survival
Primary endpoint: Time to Second Co-primary Outcome
Endpoint domain: Mortality/survival
Primary endpoint: Intraoperative contamination rate
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients operated on an outpatient basis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Uncorrected distance visual acuity (UCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative reduction of DLCO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rebleeding rates within 7 days
Endpoint domain: Adverse events/effects
Primary endpoint: total daily sleep time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: number of night wakings
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: length of longest sleep periods
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Lingual strength and endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voluntary cough function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reflexive cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants completing the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: uAGT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Natriuretic peptide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMV disease/treated infection occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Completion of dental procedure without rescue injection
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Having Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Days Post Retrieval Until Subject is Able to Resume Her Usual Activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ovarian Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction in Delivery Rate Prior to 37 Weeks Gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of Gastroesophageal Refluxes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Visual analogue scale pain (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory Markers/Cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: number of incidences of lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Modulation of cognitive control circuit structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: frequency of nightmares
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: nightmare effects
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma Epinephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Aciclovir amount in keratin layer of the epidermis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: smooth removal of LMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incorporation of n-3 PUFA into platelet cell membrane and myocardial tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of trough levels of serum IgG ≥ 4 g/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change of cerebrovascular reserve capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area under the concentration-time curve 0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: central visual processing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peripheral visual processing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dual task processing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life questionnaire - Core30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fatigue assessment questionnaire (FAQ)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: ZSDS = Zung Self-rating Depression Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Participant safety
Endpoint domain: Adverse events/effects
Primary endpoint: Number and type of neurodevelopmental and psychiatric disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of difficulty due to neurodevelopmental and psychiatric morbidity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Impact on daily life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of Femoroacetabular Impingement (FAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Consistent contraceptive use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: systolic blood pressure variability during sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: length of use of the catheter
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in expression of IFN-induced genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phantom limb pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum tolerated dose (MTD) of lapatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes